Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,433,099
-
Share change
-
+1,142,223
-
Total reported value
-
$6,646,000
-
Put/Call ratio
-
700%
-
Price per share
-
$1.50
-
Number of holders
-
48
-
Value change
-
+$1,709,230
-
Number of buys
-
16
-
Number of sells
-
14
Institutional Holders of OHR PHARMACEUTICAL INC - COM NEW (OHRP) as of Q4 2016
As of 31 Dec 2016,
OHR PHARMACEUTICAL INC - COM NEW (OHRP) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,433,099 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, BAILARD, INC., BlackRock Institutional Trust Company, N.A., Knoll Capital Management, LP, GEODE CAPITAL MANAGEMENT, LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Fund Advisors, and STONERIDGE INVESTMENT PARTNERS LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.